Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSerra Peinado, Carla
dc.contributor.authorGrau Exposito, Judit
dc.contributor.authorLuque Ballesteros, Laura
dc.contributor.authorNavarro Mercadé, Jordi
dc.contributor.authorGallego Rodriguez, Jenny Carolina
dc.contributor.authorMartin Castillo, Mario
dc.contributor.authorCurran Fàbregas, Adria
dc.contributor.authorBurgos Cibrian, Joaquin
dc.contributor.authorRibera Pascuet, Esteve
dc.contributor.authorRaventos Roca, Berta
dc.contributor.authorWillekens Morales, Rein Nicolas
dc.contributor.authorTorrella Domingo, Ariadna
dc.contributor.authorPlanas Ribas, Bibiana
dc.contributor.authorBadía Royes, Rosa María
dc.contributor.authorCastellví Vives, Josep
dc.contributor.authorGenesca Ferrer, Meritxell
dc.contributor.authorFalcó Ferrer, Vicenç
dc.contributor.authorBuzón Gómez, María José
dc.contributor.authorAstorga Gamaza, Antonio
dc.date.accessioned2020-03-02T13:08:47Z
dc.date.available2020-03-02T13:08:47Z
dc.date.issued2019-08-16
dc.identifier.citationSerra-Peinado C, Grau-Expósito J, Luque-Ballesteros L, Astorga-Gamaza A, Navarro J, Gallego-Rodriguez J, et al. Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab. Nat Commun. 2019 Aug 16;10:3705.
dc.identifier.issn2041-1723
dc.identifier.urihttps://hdl.handle.net/11351/4691
dc.descriptionRituximab; Reactivació viral; CD20
dc.description.sponsorshipThis study was supported by the American National Institutes of Health (grant R21AI118411 to M.B.), the Spanish Secretariat of Science and Innovation and FEDER funds (grant SAF2015-67334-R [MINECO/FEDER]), the Spanish "Ministerio de Economia y Competitividad, Instituto de Salud Carlos III" (ISCIII, PI17/01470), GeSIDA and the Spanish AIDS network Red Tematica Cooperativa de Investigacion en SIDA (RD16/0025/0007). M.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179). M.G. is supported by the "Pla estrategic de recerca i innovacio en salut" (PERIS), from the Catalan Government.
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.ispartofseriesNature Communications;10
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectRituximab
dc.subjectInfeccions per VIH
dc.subjectCèl·lules T
dc.subject.meshRituximab
dc.subject.meshHIV Infections
dc.subject.meshCD4-Positive T-Lymphocytes
dc.titleExpression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s41467-019-11556-4
dc.subject.decsrituximab
dc.subject.decsinfecciones por VIH
dc.subject.decslinfocitos T CD4-positivos
dc.relation.publishversionhttps://www.nature.com/articles/s41467-019-11556-4
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Serra-Peinado C, Grau-Expósito J, Luque-Ballesteros L, Astorga-Gamaza A, Navarro J, Gallego-Rodriguez J, Martin M, Curran A, Burgos J, Ribera E, Raventós B, Willekens R, Torrella A, Planas B, Badía R, Genescà M, Falcó V, Buzon MJ] Servei de Malalties Infeccioses, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR). Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Castellví J] Servei de Patologia, Hospital Universitari Vall d’Hebron. Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain
dc.identifier.pmid31420544
dc.identifier.wos000481604300011
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail
Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple